These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
41 related articles for article (PubMed ID: 21851370)
21. The use of immunosuppression in autoimmune hepatitis: A current literature review. Cropley A; Weltman M Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of autoimmune hepatitis]. Múzes G Orv Hetil; 2003 Jul; 144(30):1497-8. PubMed ID: 14569681 [No Abstract] [Full Text] [Related]
30. Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Iaccarino L; Rampudda M; Canova M; Della Libera S; Sarzi-Puttinic P; Doria A Autoimmun Rev; 2007 Jan; 6(3):190-5. PubMed ID: 17289556 [TBL] [Abstract][Full Text] [Related]
31. [Autoimmune liver disease: diagnosis and therapy]. Bayer EM; Schramm C; Kanzler S; Lohse AW Z Gastroenterol; 2004 Jan; 42(1):19-30. PubMed ID: 14997400 [TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Fulton B; Markham A Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168 [TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil for the management of autoimmune bullous diseases. Eskin-Schwartz M; David M; Mimouni D Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143 [TBL] [Abstract][Full Text] [Related]
35. Mycophenolate mofetil for patients with autoimmune hepatitis and overlap syndromes. García-Buey L; Moreno-Otero R Aliment Pharmacol Ther; 2011 Sep; 34(6):682-4; author reply 684-5. PubMed ID: 21851370 [No Abstract] [Full Text] [Related]
36. Mycophenolate mofetil--a new treatment for autoimmune hepatitis? Dhawan A; Mieli-Vergani G J Hepatol; 2000 Sep; 33(3):480-1. PubMed ID: 11020006 [No Abstract] [Full Text] [Related]
37. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy. Fallatah HI; Akbar HO Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):517-22. PubMed ID: 21780898 [TBL] [Abstract][Full Text] [Related]
38. Drug choices in autoimmune hepatitis: part B--Nonsteroids. Czaja AJ Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712 [TBL] [Abstract][Full Text] [Related]